Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 2013. The report serves as a notification of a specific corporate governance change rather than a financial results announcement.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. No financial data is included in this document.
Material Changes
The only material change disclosed is a personnel update regarding the Corporate Responsibility Committee. Sir Robert Wilson joined the committee effective May 1, 2013.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items.
Key Facts for Investors
- Sir Robert Wilson joined the Corporate Responsibility Committee on May 1, 2013.
- This filing contains no financial performance data or forward-looking statements.
- The report was signed by Victoria Whyte, Company Secretary, on May 2, 2013.